Parallel Advisors’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Parallel Advisors’s Portfolio FMED Stock Details FMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$12.8K	Hold	394	–	–	﹤0.01%	2922
2026 Q2	$11.2K	Buy	+394	New	+$10K	﹤0.01%	2897

Other funds holding FMED

Spire Wealth Management Mclean, Virginia $3.27B AUM 30.11% 1-Year Est. Return

Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

Rydar Equities Weatherford, Texas $194M AUM 23.21% 1-Year Est. Return

Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

Glass Jacobson Investment Advisors Owings Mills, Maryland $326M AUM 13.52% 1-Year Est. Return

Parallel Advisors's FMED Position: Q3 2026 in Review

Parallel Advisors held its Fidelity Disruptive Medicine ETF (FMED) position steady in Q3 2026 at 394 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2922.

Parallel Advisors first reported a position in FMED in Q2 2026 and has held it in 2 quarters since. 6 funds tracked by Wall St. Rank hold FMED as of Q3 2026.

Parallel Advisors held 394 shares of Fidelity Disruptive Medicine ETF worth $12.8K as of Q3 2026.
Parallel Advisors left its Fidelity Disruptive Medicine ETF share count unchanged in Q3 2026.
Fidelity Disruptive Medicine ETF made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #2922 holding.
Parallel Advisors first reported a position in Fidelity Disruptive Medicine ETF in Q2 2026 and has held it in 2 quarters since.
6 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.